Intuitive Surgical (ISRG)

It's important to look beyond short-term challenges with these stocks.

Salesforce is a "little tough right now," Jim Cramer said. "I want to see what happens with the quarter."

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - specialty stocks, starting with Intuitive Surgical (NASDAQ:ISRG).

The stock market is currently experiencing a profound transformation, driven by the relentless rise of Artificial Intelligence (AI). This technological revolution is not merely a fleeting trend but a fundamental shift, propelling unprecedented growth within the tech sector and attracting colossal investments from industry titans. The immediate implications are clear:

The U.S. and Japan announced a big trade deal that lowers tariffs to just 15% on imports, and the team discusses earnings from General Motors, Intuitive Surgical, and Enphase Energy.

The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.

These growth stocks are leading the way in their respective industries.

These top growth stocks have plenty of room left to run.

Ark Invest bought into some of its leaders and laggards on Monday.

The stock has a long history of making long-term shareholders very wealthy.

Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 21.4% year on year to $2.44 billion. Its non-GAAP profit of $2.19 per share was 14.2% above analysts’ consensus estimates.

Robotics healthcare giant Intuitive Surgical handily beat expectations in Q2. Shares stayed flat; the bullish long-term outlook for this stock rides on.

A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk appetite across global markets.

Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 21.4% year on year to $2.44 billion. Its non-GAAP profit of $2.19 per share was 14.3% above analysts’ consensus estimates.

Intuitive Surgical reports second-quarter revenue of $2.44 billion, beating analyst estimates of $2.35 billion, according to Benzinga Pro.

Intuitive Surgical stock fell late Tuesday after the robotic surgery giant beat second-quarter forecasts.

Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be announcing earnings results this Tuesday after market hours. Here’s what to look for.

It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical wave of tech earnings.